Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
CuriosityStream
CURI
$210M
| $1.32M | ﹤0.01% |
446,617
+25,366
| +6% | +$85.6K |
|
|
BIOA
3027
BioAge Labs
BIOA
$487M
| $1.32M | ﹤0.01% |
75,568
+14,008
| +23% | +$270K |
|
3028
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $1.32M | ﹤0.01% |
12,220
-1,449
| -11% | -$169K |
|
3029
ARS Pharmaceuticals
SPRY
$561M
| $1.32M | ﹤0.01% |
164,064
+1,058
| +0.6% | +$10.1K |
|
3030
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.87B
| $1.32M | ﹤0.01% |
54,274
+14,713
| +37% | +$357K |
|
|
JOYY
3031
JOYY Inc
JOYY
$3.68B
| $1.31M | ﹤0.01% |
22,512
-570
| -2% | -$36K |
|
3032
Bioventus
BVS
$1.2B
| $1.31M | ﹤0.01% |
143,909
-6,193
| -4% | -$51.9K |
|
|
AHRT
3033
AH Realty Trust
AHRT
$506M
| $1.31M | ﹤0.01% |
238,795
-222,074
| -48% | -$1.42M |
|
3034
ClearPoint Neuro
CLPT
$468M
| $1.31M | ﹤0.01% |
143,747
+40,741
| +40% | +$514K |
|
|
HPP
3035
Hudson Pacific Properties
HPP
$754M
| $1.31M | ﹤0.01% |
221,081
+15,229
| +7% | +$117K |
|
3036
Orthofix Medical
OFIX
$421M
| $1.3M | ﹤0.01% |
113,605
-191
| -0.2% | -$2.52K |
|
3037
BlueLinx
BXC
$680M
| $1.29M | ﹤0.01% |
23,887
-757
| -3% | -$49.7K |
|
3038
Equinor
EQNR
$96.8B
| $1.28M | ﹤0.01% |
30,394
+6,384
| +27% | +$192K |
|
3039
Smith & Nephew
SNN
$12.5B
| $1.28M | ﹤0.01% |
40,296
+12,900
| +47% | +$439K |
|
3040
Fidelity D&D Bancorp
FDBC
$324M
| $1.28M | ﹤0.01% |
29,575
-5,032
| -15% | -$224K |
|
3041
VanEck Junior Gold Miners ETF
GDXJ
$8.49B
| $1.28M | ﹤0.01% |
10,645
+390
| +4% | +$50.9K |
|
3042
ASP Isotopes
ASPI
$538M
| $1.28M | ﹤0.01% |
289,009
+45,022
| +18% | +$266K |
|
3043
STMicroelectronics
STM
$48.5B
| $1.28M | ﹤0.01% |
36,917
+6,143
| +20% | +$192K |
|
3044
Sana Biotechnology
SANA
$1.06B
| $1.27M | ﹤0.01% |
442,604
-14,622
| -3% | -$57.6K |
|
3045
Altimmune
ALT
$572M
| $1.27M | ﹤0.01% |
413,503
+59,302
| +17% | +$252K |
|
3046
PCB Bancorp
PCB
$399M
| $1.27M | ﹤0.01% |
56,585
-5,939
| -9% | -$133K |
|
3047
SI-BONE Inc
SIBN
$848M
| $1.27M | ﹤0.01% |
100,642
-2,702
| -3% | -$42.3K |
|
3048
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
| $1.27M | ﹤0.01% |
52,392
+14,792
| +39% | +$358K |
|
|
CMU
3049
DELISTED
MFS High Yield Municipal Trust
CMU
| $1.27M | ﹤0.01% |
354,378
+35,963
| +11% | +$128K |
|
3050
Yext
YEXT
$594M
| $1.27M | ﹤0.01% |
330,117
-8,893
| -3% | -$53.5K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.